📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models. (2021)

First Author: Davies SP

Attributed to: Elements of Bioremediation, Biomanufacturing & Bioenergy (E3B): Metals in Biology funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2021.660490

PubMed Identifier: 34421587

Publication URI: http://europepmc.org/abstract/MED/34421587

Type: Journal Article/Review

Volume: 12

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812